Description

Meadows et al studied secondary malignant neoplasms (SMN) in children treated for a malignancy. This has become a significant problem when children survive into adulthood. The authors are members of the Late Effects Study Group and are from multiple universities in North America and Europe.


 

Common SMNs are:

(1) bone sarcomas (associated with radiation therapy)

(2) soft tissue sarcoma

(3) acute leukemia

(4) malignant lymphoma (Hodgkin's or non-Hodgkin's)

(5) skin cancer (malignant melanoma, squamous cell carcinoma, other)

(6) malignant brain tumors

(7) thyroid carcinoma

(8) breast carcinoma

 

Risk factors for secondary malignant neoplasms:

(1) longer duration of survival

(2) tumor associated with a genetic susceptibility to cancer

(3) family history of cancer

(4) high dose radiation therapy

(5) high dose chemotherapy with anthracyclines and certain other agents

 

A genetic susceptibility to cancer can be seen with:

(1) retinoblastoma

(2) neurofibromatosis

(3) nevoid basal cell carcinoma

(4) xeroderma pigmentosa

 

Some patients may develop an SMN without any known risk factors.

 


To read more or access our algorithms and calculators, please log in or register.